Ghana: GAEC secures funding from IAEA to develop disease-tolerant cassava

Published 2021년 6월 21일

Tridge summary

The International Atomic Energy Agency (IAEA) has allocated €40,240 to the Biotechnology and Nuclear Agriculture Research Institute (BNARI) of the Ghana Atomic Energy Commission (GAEC) to develop cassava varieties that are resistant to the Cassava Brown Streak Disease (CBSD), caused by the Cassava Brown Streak Virus (CBSV) and Ugandan Cassava Brown Streak Virus (UCBSV). This project, running from 2021 to 2026, aims to use nuclear and molecular techniques, along with biotechnology, to generate genetic diversity in cassava for CBSD tolerance. The research could potentially enhance the resilience of cassava, a crucial staple crop for around 700 million Africans, against viral diseases, thereby enhancing food security.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

The International Atomic Energy Agency (IAEA) has approved €40,240 funding for the Biotechnology and Nuclear Agriculture Research Institute (BNARI) of the Ghana Atomic Energy Commission (GAEC) to produce cassava varieties that are tolerant to the Cassava Brown Streak Disease (CBSD). CBSD is caused by the Cassava Brown Streak Virus (CBSV) and Ugandan Cassava Brown Streak Virus (UCBSV), and reports of its occurrence in Burundi and the Democratic Republic of Congo indicate that the virus is spreading towards the West Africa region which hitherto was considered as CBSD-free. The lead researcher on the project, Dr. Wilfred Elegba, who is a Research Scientist at BNARI, made these remarks in an interview and noted that the project would help develop varieties tolerant to CBSD to prevent pandemics in West Africa. "Cassava is an important staple crop that provides food and income for about 700 million Africans. However, its production in sub-Saharan Africa is severely constrained ...
Source: Ghanaweb

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.